Investigation of <i>Toxoplasma gondii</i> Seroprevalence in Preeclampsic Pregnant
PDF
Cite
Share
Request
Original Investigation
P: 209-213
December 2023

Investigation of Toxoplasma gondii Seroprevalence in Preeclampsic Pregnant

Turkiye Parazitol Derg 2023;47(4):209-213
1. Sivas Cumhuriyet Üniversitesi, Sağlık Bilimleri Enstitüsü, Tıbbi Parazitoloji Anabilim Dalı, Sivas, Türkiye
2. Sivas Cumhuriyet Üniversitesi Tıp Fakültesi, Tıbbi Parazitoloji Anabilim Dalı, Sivas, Türkiye
No information available.
No information available
Received Date: 24.12.2022
Accepted Date: 11.08.2023
Publish Date: 27.12.2023
PDF
Cite
Share
Request

ABSTRACT

Objective:

Toxoplasma gondii is the causative agent of toxoplasmosis and is a parasite of high medical importance with a wide host variety. Bacterial, viral, and parasitic infections during pregnancy may predispose women to pregnancy complications. Preeclampsia of unknown etiology causes special conditions such as systemic vascular endothelial damage due to insufficient trophoblastic invasion and abnormal placentation. There are data of an association between various maternal infections and preeclampsia/eclampsias. The aim of the study was to compare and analyze the relationship between the presence of anti-Toxoplasma IgM and anti-Toxoplasma IgG antibodies in pregnant women with pre-eclampsia and in normotensive healthy pregnant women who were in the control group.

Methods:

In this study, 176 pregnant women who applied to our hospital between January 2019 and December 2020 were included. 88 (50%) of the pregnant women had pre-eclampsia and 88 (50%) were normotensive. The presence of anti-Toxoplasma IgM and IgG antibodies in blood taken from pregnant women with pre-eclampsia and control group was investigated using ELISA.

Results:

Because of the study, both groups were found to be seronegative in terms of anti-Toxoplasma IgM by ELISA. Anti-Toxoplasma IgG was found to be seropositive in 24 (27.3%) pregnant women with pre-eclampsia and 18 (20.5%) normotensive pregnant women. There was no statistically significant difference between the two groups in terms of anti-Toxoplasma IgM and anti-Toxoplasma IgG seropositivity (X2=0.289, p>0.05) (p<0.05).

Conclusion:

Because of the study, no statistically significant difference was found between pregnant women with pre-eclampsia and those with toxoplasmosis. It was thought that further studies should be conducted to discuss the hormonal, vascular, etc. factors occurring in the pathogenesis of preeclampsia of T. gondii effect of preparing the ground for the changes and to reveal the existence of a possible relationship between pre-eclampsia and T. gondii seropositivity.

Keywords: Toxoplasma gondii, preeclampsia, ELISA, immunoglobulin

References

1
Saygı G. Temel Tıbbi Parazitoloji. Erciyes Üniversitesi Yayınları No: 206: Kayseri; 2016; 104-13.
2
Durdu B. Sağlıklı Gebelerde Toxoplasma gondii Seropozitifliği, IgG Avidite Değerlerinin İncelenmesi ve Seropozitifliğe Etki Eden Çeşitli Risk Faktörlerinin Araştırılması Uzmanlık Tezi. İstanbul: Haseki Eğitim ve Araştırma Hastanesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği; 2008.
3
Çelebi S, Öcal M. Toksoplasmozis. Güncel Pediatri 2004; 2: 152-6.
4
Çetin C, Özsürmeli M, Sucu M, Çetin C, Evrüke C. Gebelik ve Toksoplazma Enfeksiyonu. Arşiv Kaynak Tarama Dergisi 2016; 25: 457-66.
5
Kuk S, Özden M. Hastanemizde Dört Yıllık Toxoplasma gondii Seropozitifliğinin Araştırılması. Türkiye Parazitol Derg 2007; 31: 1-3.
6
Caner A, Gürüz AY. Toxoplasmosis. (Ed.) Korkmaz M, Ok ÜZ. Parazitolojide Laboratuvar. Türkiye Parazitoloji Derneği yayınları: 23, İzmir, 2011; 261-84.                         
7
Özdemir F. Preeklampsi Ve İntrauterin Gelişme Geriliği Olgularında Kan Ve İdrar Nefrin Düzeylerinin Karşılaştırılması Uzmanlık Tezi. Kayseri: Erciyes Üniversitesi Tıp Fakültesi Kadın Hastalıkları Ve Doğum Anabilim Dalı; 2014.
8
Nourollahpour SM, Behboodi MZ, Adam I, Sabre V, Bagheri M, Rostami A.  Human infectious diseases and risk of preeclampsia: an update dreview of the literature. Infection 2017; 45: 589-600.
9
Rustveld LO, Kelsey SF, Sharma R. Association between maternal infectionsand preeclampsia: a systematicreview of epidemiologicstudies. Matern Child Health J 2008; 12: 223-42.
10
Trogstad LIS, Eskild A, Bruu AL, Jeansson S, Jenum PA.  Is preeclampsia an infectious disease? Acta Obstet Gynecol Scand 2001; 80: 1036-8.         
11
Soydinc HE, Kan I, Dal T, Evsen MS, Sak ME, Ozler A, et al. Evaluation of the   relationship between preeclampsia and seropositivity of infectious disease in maternal  plasma. Clin Ter 2013; 164: 199-202. 
12
Alshareef SA, Nasr AM, Adam I. Toxoplasma gondii infection and pre-eclampsia among Sudanese women. Trans R Soc Trop Med Hyg 2018; 112: 393-6.
13
Hung CC, Hayranı C, Su KC, Sung FC, Chiou HC, Gil V, et al. Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Rebublic of Sao Tome and Principe. Trans R  Soc Trop Med Hyg  2007; 101: 134-9.
14
Guerra García C, Fernández Sampedro J. Seroprevalence of Toxoplasma gondii in pregnant women. Aten Primaria 1995; 16: 151-3. 
15
Harma M, Harma M, Gungen N, Demir N. Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia City, Turkey. J Egypt Soc Parasitol 2004; 34: 519-25. 
16
Çubuk F, Hasbek M, Taşkın Kafa AH, Çelik C. Hastanemize Başvuran Gebelerde Toksoplazma, Rubella Virüs ve Sitomegalovirus Enfeksiyonları İçin Serolojik Göstergelerin Değerlendirilmesi. Turk Mikrobiyol Cemiy Derg 2020; 50: 211-7.
17
Gonca S, Serin MS, Halepliler S, Erden Ertürk S. Mersin’de Bir Devlet Hastanesine Başvuran Gebelerde Toxoplasma gondii Seroprevalansı, 2019. Turkiye Parazitol Derg 2021; 45: 176-180.
18
Kasap B, Öner G, Küçük M, Öztürk Turhan N, Akın MN, Arıkan S, et al. Muğla’daki gebelerin toksoplazma, rubella, sitomegalovirüs ve hepatit prevalansının değerlendirilmesi. Tepecik Eğit. ve Araşt. Hast. Dergisi 2017;  27: 31-6.
19
Galván-Ramírez ML, Gutiérrez-Maldonado AF, Verduzco-Grijalva F, Jiménez JMD. The role of hormones on Toxoplasma gondii infection: a systematic review. Front Microbiol 2014; 5: 503.
20
Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 2009; 39: 1385-94.  
21
Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW. Neuropsychiatric Disease and Toxoplasma gondii Infection. Neuroimmunomodulation 2009; 16: 122-33. 
22
Dzitko K, Gatkowska J, Płociński P, Dziadek B, Długońska H. The effect of prolactin (PRL) on thegrowth of Toxoplasma gondii tachyzoites in vitro. Parasitol Res 2010; 107: 199-204.
23
Alvarado-Esquivel C, Vázquez-Alaníz, F, Sandoval-Carrillo AA, Salas-Pacheco JM, Hernández-Tinoco J, Sánchez-Anguiano LF, et al. Lack of association between Toxoplasma gondii infection and hypertensive disorders in pregnancy: a case–control study in a Northern Mexican population. Parasit Vectors 2014; 7: 167.
24
Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008; 198: 7-22.  
25
Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med 2009; 22: 124-8. 
26
Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA, et al. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. Plos One 2011; 6: e23866.  
2024 ©️ Galenos Publishing House